Boston Scientific Corp (BSX) Q3 2024 Earnings Call Highlights: Robust Growth and Strategic ...

By Yahoo! Finance | Oct 24, 2024 at 03:04 AM EST

The rapid adoption of FARO Pulse in AF ablations is surpassing expectations, with an anticipated market share of over 60% by 2026. Despite a trial pause, FARO Pulse's safety and efficacy are well-established, positioning it as a leader in a competitive landscape.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.